Skip to content
10-Q/A

Quarterly Report

NUNZIA PHARMACEUTICAL COMPANY

0001683168-22-002047

← back to feed
Filed
Mar 29, 2022 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Mar 21, 2022 434.12M sh
Operating Cash Flow restated Q1 2021 · Mar 31, 2021 $16.62K
Operating Cash Flow restated Q1 2021 · Mar 31, 2020 $4.29K
Stockholders Equity restated Q1 2021 · Mar 31, 2021 −$75.05K
Stockholders Equity Q1 2021 · Mar 21, 2021 −$75.05K
Stockholders Equity restated Q1 2021 · Dec 31, 2020 −$59.4K
Current Liabilities Q1 2021 · Mar 31, 2021 $68.67K
Current Liabilities Q1 2021 · Mar 21, 2021 $68.97K
Current Liabilities Q1 2021 · Dec 31, 2020 $36.4K
Total Liabilities Q1 2021 · Mar 31, 2021 $91.67K
Total Liabilities Q1 2021 · Mar 21, 2021 $91.97K
Total Liabilities Q1 2021 · Dec 31, 2020 $59.4K
Current Assets Q1 2021 · Mar 31, 2021 $16.62K
Current Assets Q1 2021 · Mar 21, 2021 $16.62K
Current Assets Q1 2021 · Dec 31, 2020 $0
Total Assets Q1 2021 · Mar 31, 2021 $16.62K
Total Assets Q1 2021 · Mar 21, 2021 $16.62K
Total Assets Q1 2021 · Dec 31, 2020 $0
Eps Basic Q1 2021 · Mar 31, 2021 $0.00
Eps Basic Q1 2021 · Mar 31, 2020 $0.00
Sga Expense Q1 2021 · Mar 31, 2021 $15.65K
Sga Expense Q1 2021 · Mar 31, 2020 $6.9K
Net Income Q1 2021 · Mar 31, 2021 −$15.65K
Net Income Q1 2021 · Mar 31, 2020 −$6.9K
Operating Income Q1 2021 · Mar 31, 2021 −$15.65K
Operating Income Q1 2021 · Mar 31, 2020 −$6.9K
Revenue Q1 2021 · Mar 31, 2021 $0
Revenue Q1 2021 · Mar 31, 2020 $0